DB

Deepanshu Bhanot

Active Director Director DIN 08538685
DIN 08538685 First appointment Aug 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2019
Shareholding value •••• Premium profile

About Deepanshu Bhanot

Data last updated:

Deepanshu Bhanot is a Director at Aumclinics Private Limited (since 2019). The company operates in Healthcare. Aumclinics Private Limited reported revenue of ₹1.81 Cr (FY 2025).

DIN 08538685
Primary Designation Director
Industry Healthcare
First Appointment 16 Aug 2019
Oldest Company Age 7 yrs
Largest company Aumclinics Private Limited · ₹1.81 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Aumclinics Private Limited U85190DL2019PTC353913
Director16 Aug 20192019₹1.81 Cr (FY 2025)Active

Board colleagues of Deepanshu Bhanot

NameDINCompanyDesignation
Ashish Bhanot08529061Aumclinics Private LimitedDirector

Directorship timeline

Open interactive timeline →
Aumclinics Private Limited
Premium access

Shareholding and investment profile for Deepanshu Bhanot

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Deepanshu Bhanot

Deepanshu Bhanot currently holds 1 directorship: Aumclinics Private Limited (Director, since 16 Aug 2019, revenue ₹1.81 Cr (FY 2025)).

Deepanshu Bhanot was first appointed on 16 Aug 2019 as Director at Aumclinics Private Limited.

The current boards of Deepanshu Bhanot's companies include Ashish Bhanot (Aumclinics Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available